UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053627
Receipt number R000061204
Scientific Title The retrospective study of comparing pancreatic juice cytology method and cell block method for malignant pancreatic disease diagnosis
Date of disclosure of the study information 2024/03/14
Last modified on 2024/02/25 12:13:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The retrospective study of comparing pancreatic juice cytology method and cell block method using collected pancreatic juice for pathological diagnosis of malignant pancreatic disease.

Acronym

The retrospective study of comparing pancreatic juice cytology method and cell block method using collected pancreatic juice for pathological diagnosis of malignant pancreatic disease.

Scientific Title

The retrospective study of comparing pancreatic juice cytology method and cell block method for malignant pancreatic disease diagnosis

Scientific Title:Acronym

The retrospective study of comparing pancreatic juice cytology method and cell block method for malignant pancreatic disease diagnosis

Region

Japan


Condition

Condition

Pancreatic disease

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the diagnosis efficacy (sensitivity, specificity, positive predictive value, negative predictive value, and accuracy) of the pancreatic juice cytology method and cell block method using collected pancreatic juice for malignant pancreatic disease.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The diagnosis efficacy (sensitivity, specificity, positive predictive value, negative predictive value and accuracy) of pancreatic juice cytology method and cell block method using collected pancreatic juice for malignant pancreatic disease.

Key secondary outcomes

The quality of cell block specimen.
The quality of immunostaining of the cell block specimen.
The diagnosis efficacy of several times bile cytology.
The adverse event of endoscopic procedure.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

120 years-old >=

Gender

Male and Female

Key inclusion criteria

The patients with pancreatic duct stricture suspicious of malignancy
The patients who was able to place ENPD tube, and collect pancreatic juice for cytology and cell block method

Key exclusion criteria

Age < 20 years
The patients who was not able to place ENBD
The patients who were already diagnosed cytologically or histologically before this study
Unwillingness to participate in this study
The patients who are otherwise judged by the investigator to be ineligible to participate in the study

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Mitsuru
Middle name
Last name Okuno

Organization

Gifu Municipal Hospital

Division name

Department of Gastroenterology

Zip code

500-8513

Address

7-1 Kasima-cho, Gifu city, Gifu

TEL

058-251-1101

Email

mkobdkl@yahoo.co.jp


Public contact

Name of contact person

1st name Mitsuru
Middle name
Last name Okuno

Organization

Gifu Municipal Hospital

Division name

Department of Gastroenterology

Zip code

500-8513

Address

7-1 Kasima-cho, Gifu city, Gifu

TEL

058-251-1101

Homepage URL


Email

mkobdkl@yahoo.co.jp


Sponsor or person

Institute

Other

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gifu Municipal Hospital

Address

7-1 Kasima-cho, Gifu city, Gifu

Tel

058-251-1101

Email

mkobdkl@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 03 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 02 Month 16 Day

Date of IRB

2024 Year 02 Month 16 Day

Anticipated trial start date

2024 Year 02 Month 16 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2024 Year 02 Month 15 Day

Last modified on

2024 Year 02 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061204


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name